AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1187285 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as part of double-blind design)
Number of subjects: 0
Study 31036422 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone channeling
Number of subjects: 23
Study 31036422 — intervention group
Group type: COMPARATOR
Intervention: No channeling
Number of subjects: 23
Study 29141713 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD‐TDV group (N = 17,230)
Number of subjects: 25826
Study 29141713 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 8,596)
Number of subjects: 25826
Study 29141713 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD‐TDV group
Number of subjects: 25826
Study 24717791 — intervention group
Group type: EXPERIMENTAL
Intervention: as-needed budesonide/formoterol (160/4.5 micrograms; n = 32)
Number of subjects: 63
Study 24717791 — intervention group
Group type: COMPARATOR
Intervention: salbutamol (100 micrograms; n = 31)
Number of subjects: 63
Study 23580444 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise training with wireless monitoring (CR, n = 26)
Number of subjects: 55
Study 23580444 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC, n = 29)
Number of subjects: 55
Study 19995858 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 96
Study 19995858 — intervention group
Group type: COMPARATOR
Intervention: No colchicine
Number of subjects: 96
Study 19995858 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressives
Number of subjects: 96
Study 19049687 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month psychotherapy intervention (N = 9)
Number of subjects: 58
Study 19049687 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients (N = 14)
Number of subjects: 58
Study 16613260 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 90
Study 16613260 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus Sanpu Xinnao Xin granule (Group B)
Number of subjects: 90
Study 16613260 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus Xiaoyao pill (Group C)
Number of subjects: 90
Study 12814811 — intervention group
Group type: EXPERIMENTAL
Intervention: ORTHO TRI‐CYCLEN Lo (NGM 180/215/250 microg/EE 25 microg)
Number of subjects: 250
Study 12814811 — intervention group
Group type: COMPARATOR
Intervention: ORTHO TRI‐CYCLEN (NGM 180/215/250 microg/EE 35 microg)
Number of subjects: 250
Study 12814811 — intervention group
Group type: EXPERIMENTAL
Intervention: ORTHO TRI‐CYCLEN Lo
Number of subjects: 250
Study 12814811 — intervention group
Group type: COMPARATOR
Intervention: ORTHO TRI‐CYCLEN
Number of subjects: 250
Study 10655394 — intervention group
Group type: EXPERIMENTAL
Intervention: FluMist vaccine (cold-adapted H1N1, H3N2, and B influenza viruses)
Number of subjects: 0
Study 8936754 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy
Number of subjects: 19
Study 8936754 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 19
Study 1564689 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rinsing with 0.2 percent neutral NaF solution and chewing 2.2 mg NaF tablet
Number of subjects: 640
Study 1564689 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride tablets (2.2 mg NaF tablet)
Number of subjects: 640
Study 1564689 — intervention group
Group type: COMPARATOR
Intervention: Fluoride rinse (0.2 percent neutral NaF solution)
Number of subjects: 640
Study 4076202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (10 mg)
Number of subjects: 20
Study 4076202 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (10 mg)
Number of subjects: 20
Study 4076202 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Nicardipine + Metoprolol)
Number of subjects: 20
Study 4076202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (10 mg) during dynamic exercise
Number of subjects: 20
Study 4076202 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (10 mg) during dynamic exercise
Number of subjects: 20
Study 4076202 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Nicardipine + Metoprolol) during dynamic exercise
Number of subjects: 20
Study 30526273 — intervention group
Group type: COMPARATOR
Intervention: Seated control
Number of subjects: 9
Study 30526273 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% LPA
Number of subjects: 9
Study 30526273 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% LPA
Number of subjects: 9
Study 30526273 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% LPA
Number of subjects: 9
Study 29611029 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive rapid genetic counseling and testing (RGCT)
Number of subjects: 330
Study 29611029 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 330
Study 26683007 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellous iliac bone graft
Number of subjects: 15
Study 26683007 — intervention group
Group type: COMPARATOR
Intervention: 0.5 ml of HA/Col
Number of subjects: 15
Study 25060156 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin and dihydrocapsaicin combination in 30c potency
Number of subjects: 22
Study 25060156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 22564839 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg ofloxacin daily
Number of subjects: 65
Study 22564839 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,600 mg ofloxacin daily
Number of subjects: 65
Study 20575288 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with acupoint-injection of botulinum toxin A (Group A)
Number of subjects: 38
Study 20575288 — intervention group
Group type: COMPARATOR
Intervention: Acupoint-injection of botulinum toxin A (Group B)
Number of subjects: 38
Study 20575288 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (Group C)
Number of subjects: 38
Study 18092249 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid vaccination schedule (hepatitis B)
Number of subjects: 51
Study 18092249 — intervention group
Group type: COMPARATOR
Intervention: Accelerated vaccination schedule (hepatitis B)
Number of subjects: 51
Study 18092249 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid vaccination schedule (combined hepatitis A/B)
Number of subjects: 51
Study 18092249 — intervention group
Group type: COMPARATOR
Intervention: Accelerated vaccination schedule (combined hepatitis A/B)
Number of subjects: 51
Study 18092249 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid vaccination schedule (hepatitis A)
Number of subjects: 51
Study 18092249 — intervention group
Group type: COMPARATOR
Intervention: Accelerated vaccination schedule (hepatitis A)
Number of subjects: 51
Study 15590220 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation intervention based on Expanding Patient Involvement in Care (EPIC) trials
Number of subjects: 232
Study 15590220 — intervention group
Group type: COMPARATOR
Intervention: Passive education (control) via time-matched viewing of ADA video-tapes
Number of subjects: 232
Study 15590220 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation intervention
Number of subjects: 232
Study 11902267 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS preincubated with whole blood
Number of subjects: 18
Study 11902267 — intervention group
Group type: COMPARATOR
Intervention: LPS preincubated with saline
Number of subjects: 18
Study 11902267 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertriglyceridemic blood
Number of subjects: 18
Study 10502572 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction applied under ophthalmic drapes
Number of subjects: 50
Study 10502572 — intervention group
Group type: COMPARATOR
Intervention: No suction used under ophthalmic drapes
Number of subjects: 50
Study 10502572 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (suction and no suction)
Number of subjects: 50
Study 7751511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg daily
Number of subjects: 186
Study 7751511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study 1661654 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatiguing exercise of the sternomastoid muscle
Number of subjects: 10
Study 1661654 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetanic stimulation
Number of subjects: 10
Study 1661654 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal voluntary contraction
Number of subjects: 10
Study 1661654 — intervention group
Group type: COMPARATOR
Intervention: Control (pre-fatigue state)
Number of subjects: 10
Study 1661654 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatiguing exercise effect on quadriceps twitch maximum relaxation rate
Number of subjects: 10
Study 7165687 — intervention group
Group type: EXPERIMENTAL
Intervention: Hu IFN‐alpha
Number of subjects: 27
Study 7165687 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 27
Study 27240198 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine group (30 patients); aqueous iodine solution applied intrapleurally.
Number of subjects: 99
Study 27240198 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline group (34 patients); 200 mg of Doxycycline given.
Number of subjects: 99
Study 27240198 — intervention group
Group type: COMPARATOR
Intervention: Drainage group (35 patients); Lidocaine solution only applied.
Number of subjects: 99
Study 26817929 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation music (standard of care protocol with music)
Number of subjects: 197
Study 26817929 — intervention group
Group type: COMPARATOR
Intervention: Standard of care protocol (control group)
Number of subjects: 197
Study 26817929 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation music
Number of subjects: 197
Study 24395525 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day vesnarinone
Number of subjects: 3
Study 24395525 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/day vesnarinone
Number of subjects: 3
Study 24395525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 22362012 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflectometry for measuring MPOD in healthy subjects
Number of subjects: 49
Study 22362012 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflectometry for measuring MPOD in AMD patients
Number of subjects: 49
Study 20117269 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent polysaccharide pneumococcal vaccine (PPV23)
Number of subjects: 101
Study 20117269 — intervention group
Group type: COMPARATOR
Intervention: 3 doses of 7-valent pneumococcal conjugate vaccine (PCV7)
Number of subjects: 101
Study 17388708 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (40-120 mg/day)
Number of subjects: 40
Study 17388708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15578203 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg kg(‐1) body mass)
Number of subjects: 8
Study 15578203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 12168365 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia (cooled to 34 degrees C within 3 hours after injury, maintained at 32-34 degrees C for 48 hours)
Number of subjects: 14
Study 12168365 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (without hypothermia)
Number of subjects: 14
Study 10534584 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline (up to 150 mg daily)
Number of subjects: 103
Study 10534584 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (up to 30 mg daily)
Number of subjects: 103
Study 10534584 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (diphenhydramine hydrochloride up to 37.5 mg daily)
Number of subjects: 103
Study 7587902 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservation of vagal trunks (PG)
Number of subjects: 47
Study 7587902 — intervention group
Group type: COMPARATOR
Intervention: Routine severing of vagal trunks (CG)
Number of subjects: 47
Study 1969980 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 88
Study 1969980 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 88
Study 1969980 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 88
Study 358738 — intervention group
Group type: EXPERIMENTAL
Intervention: THP-induction test with fibroblast cultures
Number of subjects: 24
Study 30737046 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term weekly iron supplementation
Number of subjects: 1286
Study 30990861 — intervention group
Group type: EXPERIMENTAL
Intervention: BD MAX PCR assay
Number of subjects: 902
Study 30990861 — intervention group
Group type: EXPERIMENTAL
Intervention: GenomEra PCR assay
Number of subjects: 902
Study 30990861 — intervention group
Group type: COMPARATOR
Intervention: Combined reference standard
Number of subjects: 902
Study 27097790 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (spectral CT imaging with ASIS and 40 to 70 keV monochromatic images, ASIR algorithm)
Number of subjects: 160
Study 27097790 — intervention group
Group type: COMPARATOR
Intervention: Protocol A (120 kVp/450 mgI/kg, filtered back projection algorithm)
Number of subjects: 160
Study 25549765 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS (0.3 ng/kg body weight) injection in trained (T) group
Number of subjects: 17
Study 25549765 — intervention group
Group type: COMPARATOR
Intervention: LPS (0.3 ng/kg body weight) injection in untrained (UT) group
Number of subjects: 17
Study 23169768 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant (S) irrigation
Number of subjects: 40
Study 23169768 — intervention group
Group type: COMPARATOR
Intervention: Hypertonic saline (HS) irrigation
Number of subjects: 40
Study 22854544 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group-based CVD prevention education program (8 sessions over 6 weeks and 3 telephone interviews at 2-week intervals)
Number of subjects: 68
Study 19136337 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral sleep intervention
Number of subjects: 96
Study 19136337 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 96
Study 17420832 — intervention group
Group type: EXPERIMENTAL
Intervention: bromazepam (3mg)
Number of subjects: 10
Study 17420832 — intervention group
Group type: COMPARATOR
Intervention: placebo 1
Number of subjects: 10
Study 17420832 — intervention group
Group type: COMPARATOR
Intervention: placebo 2
Number of subjects: 10
Study 15377055 — intervention group
Group type: EXPERIMENTAL
Intervention: NADH
Number of subjects: 31
Study 15377055 — intervention group
Group type: COMPARATOR
Intervention: Nutritional supplements and psychological therapy
Number of subjects: 31
Study 11806483 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional glass-ionomer
Number of subjects: 0
Study 11806483 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer
Number of subjects: 0
Study 11806483 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental fluoride-releasing resin-based composite
Number of subjects: 0
Study 11806483 — intervention group
Group type: COMPARATOR
Intervention: Conventional resin-based composite
Number of subjects: 0
Study 9553912 — intervention group
Group type: EXPERIMENTAL
Intervention: Dithranol ointment treatment
Number of subjects: 27
Study 9553912 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 healthy subjects)
Number of subjects: 27
Study 9553912 — intervention group
Group type: EXPERIMENTAL
Intervention: Before treatment
Number of subjects: 27
Study 7934767 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min exercise duration at 70% VO2max
Number of subjects: 8
Study 7934767 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 min exercise duration at 70% VO2max
Number of subjects: 8
Study 7934767 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 min exercise duration at 70% VO2max
Number of subjects: 8
Study 7934767 — intervention group
Group type: COMPARATOR
Intervention: Control (sitting)
Number of subjects: 8
Study 3323113 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 350 mg I/mL
Number of subjects: 200
Study 3323113 — intervention group
Group type: COMPARATOR
Intervention: ioxaglate 320 mg I/mL
Number of subjects: 200
Study 28872898 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Skills Training (CST) program - six weekly telephone sessions plus access to a study website
Number of subjects: 175
Study 28872898 — intervention group
Group type: COMPARATOR
Intervention: Education program
Number of subjects: 175
Study 26727409 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 105
Study 26727409 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 105
Study 25068511 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual environment comprising 18 computer games covering mathematics topics
Number of subjects: 26
Study 25068511 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching methods (Control Group)
Number of subjects: 26
Study 22420841 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (one drop twice daily for 3 days)
Number of subjects: 46
Study 22420841 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin (1 drop 4 times daily until complete re-epithelialization)
Number of subjects: 46
Study 22420841 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 46
Study 22420841 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin
Number of subjects: 46
Study 20450634 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-driven weaning (CDW) with Smart Care/PS (SC group)
Number of subjects: 62
Study 20450634 — intervention group
Group type: COMPARATOR
Intervention: Physician-directed weaning (PDW) with synchronized intermittent mandatory ventilation plus positive support ventilation (SP group)
Number of subjects: 62
Study 20450634 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study 18681754 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 600 mg/day
Number of subjects: 180
Study 18681754 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole 200 mg/day
Number of subjects: 180
Study 18681754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 15955208 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg)
Number of subjects: 15
Study 15955208 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (20 mg)
Number of subjects: 15
Study 12437706 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral position
Number of subjects: 30
Study 12437706 — intervention group
Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 30
Study 10353376 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with schizophrenia
Number of subjects: 22
Study 10353376 — intervention group
Group type: COMPARATOR
Intervention: Normal comparison participants
Number of subjects: 22
Study 8623797 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers (smoking > or = 16 cigarettes per day)
Number of subjects: 2956
Study 8623797 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 2956
Study 8623797 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers (general)
Number of subjects: 2956
Study 1742504 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0
Study 1742504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6813481 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin (AF) 3 mg bid
Number of subjects: 242
Study 6813481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 30646500 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including food workshop, five walks, and a smartphone application for three months.
Number of subjects: 204
Study 30646500 — intervention group
Group type: COMPARATOR
Intervention: Control group received brief advice about healthy eating and physical activity.
Number of subjects: 204
Study 28373643 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed skulls
Number of subjects: 79
Study 28373643 — intervention group
Group type: COMPARATOR
Intervention: Cadaveric skulls
Number of subjects: 79
Study 28373643 — intervention group
Group type: COMPARATOR
Intervention: Atlas
Number of subjects: 79
Study 26584195 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (recombinant interleukin‐1 receptor antagonist)
Number of subjects: 763
Study 26584195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 763
Study 26584195 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 763
Study 24657803 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatrial pacing
Number of subjects: 148
Study 24657803 — intervention group
Group type: COMPARATOR
Intervention: Standardized sotalol
Number of subjects: 148
Study 19619297 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group training
Number of subjects: 100
Study 19619297 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 100
Study 17143187 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen for 15 min
Number of subjects: 12
Study 17143187 — intervention group
Group type: COMPARATOR
Intervention: Room air for 15 min
Number of subjects: 12
Study 15195012 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ml of contrast material at 4 ml/s followed by 40 ml of saline chaser at 4 ml/s
Number of subjects: 32
Study 15195012 — intervention group
Group type: COMPARATOR
Intervention: 140 ml of contrast material at 4 ml/s
Number of subjects: 32
Study 11402632 — intervention group
Group type: EXPERIMENTAL
Intervention: tolterodine 2 mg bid (total 4 mg/d)
Number of subjects: 64
Study 11402632 — intervention group
Group type: EXPERIMENTAL
Intervention: trospium chloride 15 mg tid (total 45 mg/d)
Number of subjects: 64
Study 11402632 — intervention group
Group type: EXPERIMENTAL
Intervention: oxybutynin 5 mg tid (total 15 mg/d)
Number of subjects: 64
Study 11402632 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 64
Study 9737760 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (500 mg sustained-release capsule once daily) plus low-dose dexamethasone (4 mg every 12 h)
Number of subjects: 13
Study 9737760 — intervention group
Group type: COMPARATOR
Intervention: Acetazolamide (500 mg once daily) plus placebo (every 12 h)
Number of subjects: 13